Family Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.07M Sell
890
-14
-2% -$14.3K 0.11% 122
2026
Q1
$831K Buy
904
+131
+17% +$133K 0.1% 117
2025
Q4
$831K Buy
773
+386
+100% +$369K 0.11% 100
2025
Q3
$295K Sell
387
-133
-26% -$99K 0.04% 163
2025
Q2
$405K Buy
520
+17
+3% +$13.2K 0.06% 133
2025
Q1
$415K Buy
503
+1
+0.2% +$832 0.07% 126
2024
Q4
$388K Sell
502
-64
-11% -$53K 0.06% 123
2024
Q3
$501K Sell
566
-3,427
-86% -$3.08M 0.08% 110
2024
Q2
$3.62M Buy
3,993
+210
+6% +$168K 0.64% 43
2024
Q1
$2.94M Buy
+3,783
New +$2.69M 0.54% 50

Other funds holding LLY

Family Management's LLY Position: Q2 2026 in Review

Family Management reduced its Eli Lilly (LLY) stake by 1.5% in Q2 2026, selling an estimated $14.3K and leaving 890 shares worth $1.07M. The position accounts for 0.11% of the portfolio, ranked #122.

Family Management first reported a position in LLY in Q1 2024 and has held it in 10 quarters since. The position peaked at $3.62M in Q2 2024. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Family Management held 890 shares of Eli Lilly worth $1.07M as of Q2 2026.
  • Family Management sold 14 Eli Lilly shares in Q2 2026, an estimated $14.3K.
  • Eli Lilly made up 0.11% of Family Management's portfolio in Q2 2026, its #122 holding.
  • Family Management first reported a position in Eli Lilly in Q1 2024 and has held it in 10 quarters since.
  • Family Management's Eli Lilly position peaked at $3.62M in Q2 2024.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Family Management's 13F filing for Q2 2026, filed 14 Aug 2026.